/
No Comments
Scientists and biotech researchers working on pharmaceutical and MedTech innovation as India expands R&D support under the PRIP scheme.
Scientists and biotech researchers working on pharmaceutical and MedTech innovation as India expands R&D support under the PRIP scheme.
IHH Healthcare plans to raise its Fortis Healthcare stake to 51% and expand capacity to around 10,000 beds by 2031. Pasted text
Crisil expects pharmaceutical sector revenue to grow 11–13% this fiscal year, led by exports and domestic demand.
Maharishi Ayurveda is investing €5 million in a European wellness, education and research expansion centred on a new facility in the Netherlands.
Pharmaceutical professionals conduct quality-control work at an Indian bioequivalence research facility.
A premium healthcare corporate visual representing increased promoter investment in a major hospital and healthcare network.
A pharmaceutical research and healthcare setting representing Sun Pharma's agreement with the US government.
India opens the second call under its ₹5,000-crore PRIP Scheme to support pharmaceutical and MedTech research, startups and advanced healthcare innovation.
Ophthalmic eye drops and advanced vision-care technology representing Lupin and Tenpoint Therapeutics' licensing partnership for the presbyopia treatment YUVEZZI.
Insulin pens and pharmaceutical research imagery representing Mankind Pharma's licensing partnership with Chongqing Chenan Biopharmaceutical for diabetes therapies in India.
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
